SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening

Mostrar otras versiones (1)

[Image: see text] Drug development for specific antiviral agents against coronavirus disease 2019 (COVID-19) is still an unmet medical need as the pandemic continues to spread globally. Although huge efforts for drug repurposing and compound screens have been put forth, only a few compounds are in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorshkov, Kirill, Morales Vasquez, Desarey, Chiem, Kevin, Ye, Chengjin, Nguyen Tran, Bruce, Carlos de la Torre, Juan, Moran, Thomas, Chen, Catherine Z., Martinez-Sobrido, Luis, Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751018/
https://www.ncbi.nlm.nih.gov/pubmed/35036857
http://dx.doi.org/10.1021/acsptsci.1c00182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751018/
https://www.ncbi.nlm.nih.gov/pubmed/35036857
http://dx.doi.org/10.1021/acsptsci.1c00182

Ejemplares similares